BiomX

Life Sciences

BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

[overview]
stage

founded

region

fund

No related items found.
No related items found.
[featured articles]

Related Companies

Swipe to browse more companies
Life Sciences
Government & Defense